With the increased importance of early CKD diagnosis by the advancements of CKD Clinical Practice Guidelines and the launch of SGLT2 inhibitors, we anticipated that the rate of CKD diagnosis would increase. This evidence concerns the gene SLC5A2 and chronic kidney disease.